Cargando…

Cytokines in Cancer Immunotherapy

Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another to generate a coordinated, robust, but self-limited response to a target antigen. The growing interest over the past two decades in harnessing the immune system to eradicate cancer has been a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sylvia, Margolin, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763400/
https://www.ncbi.nlm.nih.gov/pubmed/24213115
http://dx.doi.org/10.3390/cancers3043856
_version_ 1782283008205651968
author Lee, Sylvia
Margolin, Kim
author_facet Lee, Sylvia
Margolin, Kim
author_sort Lee, Sylvia
collection PubMed
description Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another to generate a coordinated, robust, but self-limited response to a target antigen. The growing interest over the past two decades in harnessing the immune system to eradicate cancer has been accompanied by heightened efforts to characterize cytokines and exploit their vast signaling networks to develop cancer treatments. The goal of this paper is to review the major cytokines involved in cancer immunotherapy and discuss their basic biology and clinical applications. The paper will also describe new cytokines in pre-clinical development, combinations of biological agents, novel delivery mechanisms, and potential directions for future investigation using cytokines.
format Online
Article
Text
id pubmed-3763400
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-37634002013-09-05 Cytokines in Cancer Immunotherapy Lee, Sylvia Margolin, Kim Cancers (Basel) Review Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another to generate a coordinated, robust, but self-limited response to a target antigen. The growing interest over the past two decades in harnessing the immune system to eradicate cancer has been accompanied by heightened efforts to characterize cytokines and exploit their vast signaling networks to develop cancer treatments. The goal of this paper is to review the major cytokines involved in cancer immunotherapy and discuss their basic biology and clinical applications. The paper will also describe new cytokines in pre-clinical development, combinations of biological agents, novel delivery mechanisms, and potential directions for future investigation using cytokines. Molecular Diversity Preservation International (MDPI) 2011-10-13 /pmc/articles/PMC3763400/ /pubmed/24213115 http://dx.doi.org/10.3390/cancers3043856 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/)
spellingShingle Review
Lee, Sylvia
Margolin, Kim
Cytokines in Cancer Immunotherapy
title Cytokines in Cancer Immunotherapy
title_full Cytokines in Cancer Immunotherapy
title_fullStr Cytokines in Cancer Immunotherapy
title_full_unstemmed Cytokines in Cancer Immunotherapy
title_short Cytokines in Cancer Immunotherapy
title_sort cytokines in cancer immunotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763400/
https://www.ncbi.nlm.nih.gov/pubmed/24213115
http://dx.doi.org/10.3390/cancers3043856
work_keys_str_mv AT leesylvia cytokinesincancerimmunotherapy
AT margolinkim cytokinesincancerimmunotherapy